Hoka maker Deckers Brands posted record Q3 earnings, revenue. But shares unravel on commentary about inventory, comparisons.

Want to switch things up for Valentine's Day this year? Watch the sunrise or sunset with your special someone on this ...

Deckers Brands on Thursday raised its full-year outlook and reported third-quarter results that topped estimates, helped by demand for Ugg boots and Hoka running shoes. But investors, apparently, had ...

Falling snow transforms the Mount Tom Tower Trail, an enchanting winter hike in Connecticut, into a wonderland with ...

But in Australia, "ugg" is more a generic term for a style of sheepskin shoe first popularized by surfers ... for welcoming our SINCE 74 mark with open arms. SINCE 74 is an ode to our heritage ...

A blue handbag and clunky open-toe shoes add a relaxed edge to the tailored ... fantastic black and white cowboy boots. Spot the Tevas Teva sandals are known for being extremely comfortable ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $16.0 to $21.0 for Teva Pharmaceutical Indus over the last 3 months.

Teva Pharmaceutical Industries' Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. Management's cautious 2025 guidance sets a low bar, likely to be ...

Despite finishing strong across both its innovative and generic businesses in 2024, Teva’s cautious approach to the new year appears to have investors spooked. Teva on Wednesday reported that ...

Teva reported growth for the second year in a row. Despite exceeding Wall Street targets, the company's guidance came up short. Teva reported earnings before trading began on Wednesday. The ...

Shares of Teva Pharmaceutical Industries (NYSE: TEVA) were slipping Wednesday. The company's stock lost 13.5% as of 1:15 p.m. ET. The leg down comes as the S&P 500 (SNPINDEX: ^GSPC) and Nasdaq ...